Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ANDERSON G. M., HULL E. The effect of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure. Am Heart J. 1950 May;39(5):697–702. doi: 10.1016/0002-8703(50)90129-3. [DOI] [PubMed] [Google Scholar]
- HARVEY W. P., FINCH C. A. Dicumarol prophylaxis of thromboembolic disease in congestive heart failure. N Engl J Med. 1950 Feb 9;242(6):208–211. doi: 10.1056/NEJM195002092420603. [DOI] [PubMed] [Google Scholar]
- MERSKEY C., DRAPKIN A. ANTICOAGULANT THERAPY. Blood. 1965 Apr;25:567–596. [PubMed] [Google Scholar]
- OWREN P. A. Indications for anticoagulant therapy. N Engl J Med. 1963 May 23;268:1173–contd. doi: 10.1056/NEJM196305232682108. [DOI] [PubMed] [Google Scholar]
- THORSEN R. K. Anticoagulation therapy for congestive heart failure. Acta Med Scand. 1957 Sep 6;158(3-4):203–212. doi: 10.1111/j.0954-6820.1957.tb15483.x. [DOI] [PubMed] [Google Scholar]
- ZINN W. J., GRIFFITH G. C. Atherosclerosis; a preventable disease? Med Clin North Am. 1952 Jul;21:1001–1012. [PubMed] [Google Scholar]